Federal contractor · PHOENIX, AZ

TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

TRANSLATIONAL GENOMICS RESEARCH INSTITUTE received $1.5M in federal contract obligations in FY2026, on 2 awards (+26% vs FY2025). Since FY2017: $14.1M. Its largest customer was National Institutes of Health ($1.5M). It also received $12.5M in federal grants and other assistance in FY2026.

Obligations · FY2026
$1.5M
New awards
2
Sole-source
0.0%
Single offer
0.0%
UEI
J19ZXYATJLT3
Other than small businessNonprofit
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 1MFY2017
  2. 1.4MFY2018
  3. 380.2KFY2019
  4. 410.1KFY2020
  5. 1.1MFY2021
  6. 127.8KFY2022
  7. 5.3MFY2023
  8. 1.6MFY2024
  9. 1.2MFY2025
  10. 1.5MFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$1.5M100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$1.5M100%

Where the work was performed

  1. Maricopa County, AZ$1.5M100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · -$15.2K
  • Sole-source awards0.0%
    US 30% · -$15.2K
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS$4.1M
    National Institutes of Health· Maricopa County, AZ· Research & development· Sep 24, 2024 – Jul 28, 2026· 75N93024C00054
  2. GENOME SEQUENCING OF DNA SAMPLES OF DRUG-RESISTANT FORMS TB BACTERIA$0
    National Institutes of Health· Maricopa County, AZ· Health & medical· Dec 10, 2020 – Jan 22, 2026· 75N93021P00144

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

TRANSLATIONAL GENOMICS RESEARCH INSTITUTE received $12.5M in federal assistance in FY2026, on 22 actions (3 new awards), −11% vs FY2025. Its largest program was 93.866 · Aging Research ($9.3M).

Assistance · FY2026
$12.5M
New awards
3
Actions
22
Since FY2021
$58.4M

Assistance by fiscal year

  1. 3.4MFY2021
  2. 4.2MFY2022
  3. 9.9MFY2023
  4. 14.2MFY2024
  5. 14.1MFY2025
  6. 12.5MFY2026

By type

  1. Grants$12.5M100%

Top programs

  1. 93.866 · Aging Research$9.3M74%
  2. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$1.8M14%
  3. 93.837 · Cardiovascular Diseases Research$807.8K6.5%
  4. 93.310 · Trans-NIH Research Support$500K4.0%
  5. 93.396 · Cancer Biology Research$249K2.0%
  6. 93.395 · Cancer Treatment Research$224.4K1.8%
  7. 10.025 · Animal Disease and Animal Care-$83.1K0.0%
  8. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders-$228.4K0.0%

Awarding agencies

  1. National Institutes of Health$12.6M100%
    Department of Health and Human Services

Largest awards

  1. CONSORTIUM TO STUDY THE GENETICS OF LONGEVITY$79.9M
    93.866 · Aging Research· National Institutes of Health· Cooperative agreement· Oct 1, 2020 – Aug 21, 2026· U19AG023122
  2. COMBINING GENOME, FUNCTION, AND PHENOTYPE TO DEFINE THE CELL TYPE SPECIFIC GENE REGULATORY ARCHITECTURE OF IDIOPATHIC PULMONARY FIBROSIS$6M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Dec 31, 2020 – May 20, 2026· R01HL145372
  3. EXTRACELLULAR VESICLE CARGO AND RISK OF NAFLD AND NASH IN LATINO YOUTH - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF PEDIATRIC NONALCOHOLIC…$3.9M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Apr 12, 2022 – Feb 18, 2026· R01DK127015
  4. PROFILING EXTRACELLULAR VESICLE CARGO IN OBESITY AND TYPE 2 DIABETES$3.7M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jul 29, 2021 – Nov 25, 2025· R01DK120890
  5. INTEGRATIVE OMICS TO ENHANCE THERAPEUTICS DEVELOPMENT FOR HEALTHY AGING - ABSTRACT/SUMMARY A NUMBER OF DRUGS AND INTERVENTIONS HAVE BEEN…$3.5M
    93.866 · Aging Research· National Institutes of Health· Cooperative agreement· Aug 26, 2021 – Mar 2, 2026· UH3AG064706
  6. HIGH-RESOLUTION, VIROME-WIDE INFECTION ANALYSIS IN TYPE 1 DIABETES BIRTH COHORTS - PROJECT ABSTRACT/SUMMARY TYPE 1 DIABETES (T1D) AFFECTS…$3.5M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· May 31, 2024 – Jun 9, 2026· R01DK140795

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

  • Sub-grants: $7,850 (1 subaward)

1 sub-recipient

  1. ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO$7,850100%
    CHICAGO, IL · 1 subaward

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $14.9M (18 subawards)

14 primes

  1. UNIVERSITY OF NEW MEXICO$8.1M54%
    ALBUQUERQUE, NM · 1 subaward
  2. THE UNIVERSITY OF CHICAGO$2.4M16%
    CHICAGO, IL · 2 subawards
  3. DIGNITY HEALTH$1.6M11%
    SAN FRANCISCO, CA · 1 subaward
  4. VANDERBILT UNIVERSITY MEDICAL CENTER$770.9K5.2%
    NASHVILLE, TN · 2 subawards
  5. UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION$550.1K3.7%
    PITTSBURGH, PA · 1 subaward
  6. ARIZONA STATE UNIVERSITY$452K3.0%
    TEMPE, AZ · 3 subawards
  7. REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE$449.8K3.0%
    SAN FRANCISCO, CA · 1 subaward
  8. NORTHWESTERN UNIVERSITY$212.7K1.4%
    EVANSTON, IL · 1 subaward
  9. YALE UNIV$192K1.3%
    NEW HAVEN, CT · 1 subaward
  10. CEDARS-SINAI MEDICAL CENTER$58.5K0.4%
    WEST HOLLYWOOD, CA · 1 subaward

By fiscal year

  • FY2021: $0 paid out · $4.5M received
  • FY2022: $626K paid out · $26M received
  • FY2023: $0 paid out · $5.3M received
  • FY2024: $3M paid out · $2.8M received
  • FY2025: $0 paid out · $5.4M received
  • FY2026: $7,850 paid out · $14.9M received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

10 companies · $3.6M reported

  1. VANDERBILT UNIVERSITY MEDICAL CENTER$728.9K
    NASHVILLE, TN · 1 subaward
  2. NEURODEX INC$677.3K
    ARLINGTON, MA · 1 subaward
  3. YALE UNIV$571.2K
    NEW HAVEN, CT · 1 subaward

Primes that pay it

34 companies · $58.8M reported

  1. UNIVERSITY OF ARIZONA$21.2M
    TUCSON, AZ · 12 subawards
  2. UNIVERSITY OF NEW MEXICO$8.8M
    ALBUQUERQUE, NM · 4 subawards
  3. UCHICAGO ARGONNE, LLC$4.2M
    CHICAGO, IL · 10 subawards

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. AN2 THERAPEUTICS, INC$4.3M−100% in FY2026
    MENLO PARK, CA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. CERAMEDIX HOLDING, LLC$4.2M+18% in FY2026
    NEW YORK, NY · 97% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. LYMPHATECH, INC$4.1M−100% in FY2026
    ATLANTA, GA · 95% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

  • Translational Genomics Research InstituteAI match · 100%
Lobbying · 2025
$40K
4 reports
Lobbying · 2023–2026
$140K

Lobbying by year

  1. 2023$40K
    4 reports
  2. 2024$40K
    4 reports
  3. 2025$40K
    4 reports
  4. 2026$20K
    2 reports

Top issues

  1. Budget and appropriations9 reports
  2. Medical and disease research, clinical labs5 reports

Who was contacted

  1. U.S. SENATE10 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

  1. First Strategic$140K
    14 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.